Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up …

S Bangalore, S Kumar, M Fusaro, N Amoroso… - Bmj, 2012 - bmj.com
Objectives To evaluate the efficacy and safety of currently used drug eluting stents
compared with each other and compared with bare metal stents in patients with diabetes …

An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials

PZ Gerczuk, RA Kloner - Journal of the American College of Cardiology, 2012 - jacc.org
Acute myocardial infarction (AMI) with subsequent left ventricular dysfunction and heart
failure continues to be a major cause of morbidity and mortality in the Western world. Rapid …

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease

A Schömig, A Dibra, S Windecker, J Mehilli… - Journal of the American …, 2007 - jacc.org
Objectives: Our purpose was to make a synthesis of the available evidence on the relative
efficacy and safety of 2 drug-eluting stents (DES)—sirolimus-eluting stent (SES) and …

Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)

JM de la Torre-Hernández, F Alfonso… - Journal of the American …, 2008 - jacc.org
Objectives: This study sought to assess the incidence, predictors, and outcome of drug-
eluting stent (DES) thrombosis in real-world clinical practice. Background: The DES …

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention

GJ Laarman, MJ Suttorp, MT Dirksen… - … England Journal of …, 2006 - Mass Medical Soc
Background Drug-eluting coronary-artery stents have been shown to decrease restenosis
and therefore the likelihood that additional procedures will be required after percutaneous …

Effectiveness and safety of drug-eluting stents in Ontario

JV Tu, J Bowen, M Chiu, DT Ko… - … England Journal of …, 2007 - Mass Medical Soc
Background The placement of drug-eluting stents decreases the frequency of repeat
revascularization procedures in patients undergoing percutaneous coronary intervention …

The evolution of coronary stents: a brief review

T Simard, B Hibbert, FD Ramirez, M Froeschl… - Canadian Journal of …, 2014 - Elsevier
Percutaneous coronary intervention is the most prevalent method for coronary artery
revascularization. Initial interventions using balloon angioplasty had limited efficacy …

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score …

S Brugaletta, T Gori, AF Low, P Tousek, E Pinar… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to compare the 1-year outcome between
bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST …

Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction

GD Dangas, A Caixeta, R Mehran, H Parise… - Circulation, 2011 - Am Heart Assoc
Background—Concerns persist regarding the risk of stent thrombosis in the setting of
primary percutaneous coronary intervention for ST-segment elevation myocardial infarction …

Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the …

M Valgimigli, G Campo, G Percoco, L Bolognese… - Jama, 2008 - jamanetwork.com
Context Abciximab infusion and uncoated-stent implantation is a complementary treatment
strategy to reduce major adverse cardiac events in patients undergoing angioplasty for ST …